日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/02/15 | 1,115 | 1,129 | 1,114 | 1,123 | +8 | +0.7% | 127,000 |
| 2011/02/14 | 1,128 | 1,128 | 1,110 | 1,115 | -4 | -0.4% | 138,000 |
| 2011/02/10 | 1,112 | 1,122 | 1,106 | 1,119 | +7 | +0.6% | 235,000 |
| 2011/02/09 | 1,105 | 1,122 | 1,103 | 1,112 | -11 | -1% | 300,000 |
| 2011/02/08 | 1,140 | 1,145 | 1,115 | 1,123 | -23 | -2% | 262,000 |
| 2011/02/07 | 1,142 | 1,148 | 1,134 | 1,146 | -2 | -0.2% | 137,000 |
| 2011/02/04 | 1,137 | 1,150 | 1,136 | 1,148 | +10 | +0.9% | 106,000 |
| 2011/02/03 | 1,138 | 1,141 | 1,130 | 1,138 | -6 | -0.5% | 79,000 |
| 2011/02/02 | 1,143 | 1,152 | 1,140 | 1,144 | ±0 | ±0% | 166,000 |
| 2011/02/01 | 1,150 | 1,150 | 1,139 | 1,144 | -10 | -0.9% | 93,000 |
| 2011/01/31 | 1,157 | 1,157 | 1,140 | 1,154 | -3 | -0.3% | 115,000 |
| 2011/01/28 | 1,152 | 1,164 | 1,150 | 1,157 | +2 | +0.2% | 202,000 |
| 2011/01/27 | 1,160 | 1,162 | 1,149 | 1,155 | -7 | -0.6% | 102,000 |
| 2011/01/26 | 1,172 | 1,172 | 1,159 | 1,162 | -10 | -0.9% | 105,000 |
| 2011/01/25 | 1,158 | 1,181 | 1,152 | 1,172 | +14 | +1.2% | 233,000 |
| 2011/01/24 | 1,141 | 1,160 | 1,140 | 1,158 | +14 | +1.2% | 163,000 |
| 2011/01/21 | 1,140 | 1,157 | 1,135 | 1,144 | -3 | -0.3% | 268,000 |
| 2011/01/20 | 1,140 | 1,150 | 1,138 | 1,147 | +1 | +0.1% | 129,000 |
| 2011/01/19 | 1,149 | 1,151 | 1,142 | 1,146 | -3 | -0.3% | 73,000 |
| 2011/01/18 | 1,154 | 1,157 | 1,148 | 1,149 | -5 | -0.4% | 134,000 |
| 2011/01/17 | 1,146 | 1,158 | 1,142 | 1,154 | +8 | +0.7% | 145,000 |
| 2011/01/14 | 1,139 | 1,154 | 1,137 | 1,146 | +12 | +1.1% | 207,000 |
| 2011/01/13 | 1,135 | 1,142 | 1,127 | 1,134 | -1 | -0.1% | 144,000 |
| 2011/01/12 | 1,146 | 1,146 | 1,129 | 1,135 | -12 | -1% | 186,000 |
| 2011/01/11 | 1,143 | 1,149 | 1,139 | 1,147 | +15 | +1.3% | 186,000 |
| 2011/01/07 | 1,146 | 1,146 | 1,132 | 1,132 | -7 | -0.6% | 139,000 |
| 2011/01/06 | 1,144 | 1,146 | 1,136 | 1,139 | -4 | -0.3% | 137,000 |
| 2011/01/05 | 1,166 | 1,166 | 1,143 | 1,143 | -23 | -2% | 234,000 |
| 2011/01/04 | 1,174 | 1,174 | 1,140 | 1,166 | +4 | +0.3% | 280,000 |
| 2010/12/30 | 1,163 | 1,168 | 1,158 | 1,162 | -9 | -0.8% | 134,000 |
| 2010/12/29 | 1,161 | 1,176 | 1,153 | 1,171 | +11 | +0.9% | 163,000 |
| 2010/12/28 | 1,154 | 1,166 | 1,145 | 1,160 | +7 | +0.6% | 104,000 |
| 2010/12/27 | 1,169 | 1,179 | 1,151 | 1,153 | -13 | -1.1% | 342,000 |
| 2010/12/24 | 1,147 | 1,170 | 1,143 | 1,166 | +30 | +2.6% | 370,000 |
| 2010/12/22 | 1,130 | 1,143 | 1,130 | 1,136 | +7 | +0.6% | 244,000 |
| 2010/12/21 | 1,118 | 1,134 | 1,118 | 1,129 | +18 | +1.6% | 199,000 |
| 2010/12/20 | 1,106 | 1,124 | 1,106 | 1,111 | -4 | -0.4% | 345,000 |
| 2010/12/17 | 1,110 | 1,121 | 1,103 | 1,115 | +5 | +0.5% | 234,000 |
| 2010/12/16 | 1,119 | 1,119 | 1,090 | 1,110 | -2 | -0.2% | 389,000 |
| 2010/12/15 | 1,103 | 1,112 | 1,100 | 1,112 | +11 | +1% | 169,000 |
| 2010/12/14 | 1,112 | 1,112 | 1,090 | 1,101 | -11 | -1% | 198,000 |
| 2010/12/13 | 1,111 | 1,113 | 1,101 | 1,112 | +2 | +0.2% | 140,000 |
| 2010/12/10 | 1,104 | 1,112 | 1,095 | 1,110 | -3 | -0.3% | 242,000 |
| 2010/12/09 | 1,104 | 1,116 | 1,104 | 1,113 | -1 | -0.1% | 132,000 |
| 2010/12/08 | 1,110 | 1,119 | 1,099 | 1,114 | +10 | +0.9% | 182,000 |
| 2010/12/07 | 1,088 | 1,105 | 1,088 | 1,104 | +4 | +0.4% | 146,000 |
| 2010/12/06 | 1,093 | 1,107 | 1,093 | 1,100 | +1 | +0.1% | 105,000 |
| 2010/12/03 | 1,090 | 1,111 | 1,090 | 1,099 | +7 | +0.6% | 203,000 |
| 2010/12/02 | 1,116 | 1,116 | 1,086 | 1,092 | -6 | -0.5% | 204,000 |
| 2010/12/01 | 1,097 | 1,103 | 1,090 | 1,098 | +7 | +0.6% | 86,000 |
3501～
3550
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 350,400円 | +8.0% | -15.3% | 3.54% | 9.84倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 333,800円 | +3.8% | -19.9% | 4.07% | 10.92倍 | 0.84倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 352,000円 | - | - | 0.00% | - | 163.04倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 169,500円 | +5.0% | +1.5% | 0.00% | 14.50倍 | 3.86倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ジーエヌアイ | 420,000円 | +21.7% | +999.9% | 0.00% | 17.59倍 | 5.82倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
